Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…
Biotechnology
US, Boston [HQ]
Insiders
Transactions
Track non-derivative insider transactions.
i = Indirect Ownership
d = Direct Ownership
cs = Common Stock
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra |
---|
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture: